# Phase 1/2 Trial of AEF0217 in Participants With Down Syndrome

> **NCT05748405** · PHASE1,PHASE2 · COMPLETED · sponsor: **Aelis Farma** · enrollment: 40 (actual)

## Conditions studied

- Down Syndrome

## Interventions

- **DRUG:** Placebo
- **DRUG:** AEF0217

## Key facts

- **NCT ID:** NCT05748405
- **Lead sponsor:** Aelis Farma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-15
- **Primary completion:** 2024-10-07
- **Final completion:** 2024-10-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05748405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05748405, "Phase 1/2 Trial of AEF0217 in Participants With Down Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05748405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*